RhomeoX ApS: Financial statements 2025
CVR: 43458078
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
RhomeoX ApS (CVR 43458078) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -16,025 and a net result of DKK -9,396 compared with DKK -14,106 the year before. Equity in the 2025 report amounted to DKK 3,368. The solvency ratio was 1.7%.
- Gross Profit
- DKK -16,025
- Profit/Loss
- DKK -9,396
- Equity
- DKK 3,368
- Total Assets
- DKK 203,661
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -16 t. | -9 t. | 3 t. | 0 |
| 2024 | - | -14 t. | -14 t. | 13 t. | - |
Official annual report
How creditworthy is RhomeoX ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
RhomeoX ApS has published its annual report for 2024. Gross profit came to DKK -14,150, and the net result was DKK -14,106.
About RhomeoX ApS
RhomeoX ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jens Christian Jensenius. The company is owned by KLITLUND ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -16,025 and a net result of DKK -9,396 compared with DKK -14,106 the year before. Equity in the 2025 report amounted to DKK 3,368.